Webinar | Software Verification and Validation in Medical Industry
The verification and validation of medical software is coming under increased scrutiny by the U.S. FDA. This webinar will address the use of the FDA, GAMP, 21 CFR Part 11, Electronic Records coupled with the ISO 14971 / ICH Q9 Product Risk Management models.
New Hyde Park, New York, April 6, 2015 (Newswire.com) - Overview
The verification and validation of medical industry software is coming under increased scrutiny by the U.S. FDA. This webinar will address the use of the FDA, GAMP, 21 CFR 11, and other applicable industry software validation models, coupled with the ISO 14971 / ICH Q9 Risk Management models, and their real-world implementation. A field-tested SW V&V documentation model will be featured.
Why Should You Attend
Software has become pervasive in medical devices themselves, and in the controlling, running and monitoring of medical product processes, whether they be in the pharmaceutical, medical device, biologics or dietary supplements industries. Software is being developed for medical imaging, and even thought control of computers for individuals having disabilities restricting hand or eye movement / coordination. The U.S. FDA rightly recognizes that virtually all software quality problems occur in the design, testing and validation phases, since replication of software is relatively defect-free. Regulatory auditors are more comfortable with delving into software issues. Recent problems in unrelated industries show the dangers of neglecting thorough, and risk based software verification activities. Effective and real world software V&V is even more important in today’s resource-constrained industrial environment. This discussion will focus on a preferred U.S. FDA documentation "model" in various applications, including ERP, in-device, as-device, process/equipment control, and cGMP data / Part 11 applications.
Areas Covered in the Session
The verification and validation of medical software is coming under increased scrutiny by the U.S. FDA. This webinar will address the use of the FDA, GAMP, 21 CFR Part 11, "Electronic Records" / "Electronic Signatures", and other applicable industry software validation models, coupled with the ISO 14971 / ICH Q9 Product Risk Management models, to structure, run, and document acceptable software validations. The FDA and other regulatory agencies have stated that software validation can only be accomplished effectively if “risk-based”. How can this be done in the "real world".
This webinar will address software that is:
1) As-Product;
2) In-Product;
3) Process and/or In Production and Test Equipment; and
4) Software used to support / document the Quality System (21 CFR Part 11).
It will focus on a field-tested (FDA and EU) “model” having 11 elements of document modules that can be used for all software validation documentation.
A manufacturer is responsible to identify these requirements and implement them into an effective software V&V process.
Learning Objectives
- Verification or Validation -- FDA Expectations
- The Project Validation Plan
- An FDA-accepted Documentation "Model"
- Product and Process / Test / Facilities / Equipment Software
- V&V
- When and How to Use DQ, IQ, OQ, PQ (or their equivalents)
- The FDA’s 11 Key V&V Documentation Elements
- “White Box” and “Black Box” Validations
- GAMP / Other Considerations
Who Will Benefit
- Senior management in Drugs, Devices, Biologics, Dietary Supplements
- QA/RA Professionals
- R&D Professionals
- Engineering Professionals
- Production Professionals
- Operations Professionals
- Consultants
For more information, please visit https://www.complianceglobal.us/product/700045
Email: referrals@complianceglobal.us
Toll Free: +1-844-746-4244
Tel: +1-516-900-5515